The mTOR Kinase Determines Effector versus Memory CD8+ T Cell Fate by Regulating the Expression of Transcription Factors T-bet and Eomesodermin
Top Cited Papers
Open Access
- 7 January 2010
- Vol. 32 (1) , 67-78
- https://doi.org/10.1016/j.immuni.2009.10.010
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Plasticity of CD4+ T Cell Lineage DifferentiationImmunity, 2009
- Programming for CD8 T Cell Memory Development Requires IL-12 or Type I IFNThe Journal of Immunology, 2009
- Cutting Edge: IL-12 Inversely Regulates T-bet and Eomesodermin Expression during Pathogen-Induced CD8+ T Cell DifferentiationThe Journal of Immunology, 2006
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- Glucose Availability Regulates IFN-γ Production and p70S6 Kinase Activation in CD8+ Effector T CellsThe Journal of Immunology, 2005
- Upstream and downstream of mTORGenes & Development, 2004
- Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T CellsThe Journal of Experimental Medicine, 2003
- IL-12 Provides Proliferation and Survival Signals to Murine CD4+ T Cells Through Phosphatidylinositol 3-Kinase/Akt Signaling PathwayThe Journal of Immunology, 2002
- Mammalian TOR: A Homeostatic ATP SensorScience, 2001
- Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivoNature Immunology, 2000